The popular recreational drug Ecstasy (3,4-methylenedioxymethamphetamine, or MDMA, and related congeners) is neurotoxic upon central serotonergic systems in animal studies. So far, the most convincing evidence for neurotoxicity-related functional deficits in humans derives from neurocognitive studie
Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users
β Scribed by A. Parrott
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 36 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.449
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty recreational drug users were asked to describe the psychological and physiological eects they experienced under MDMA (3,4-methylenedioxymethamphetamine). The subjects comprised 11 males and nine females, in the age range 18Β±31 years. Five subjects had taken MDMA once, nine had taken it 2Β±9 ti
Twenty-one recreational polydrug users (age range: 17Β±34 years), were recruited into the study using the `snowball' technique (Solowij et al., 1992). All had used MDMA (3,4-methylenedioxymethamphetamine, or `Ecstasy'), LSD (lysergic acid diethylamide), and amphetamine, on dierent occasions. They com
Chronic use of MDMA (3,4-methylenedioxymethamphetamine), or Ecstasy, is believed to lead to impaired psychological performance, including well-documented decrements in laboratory and field tests of retrospective memory. Less is known about the impact of Ecstasy on aspects of 'everyday' memory, despi
Chronic use of MDMA (3,4-methylenedioxymethamphetamine), or 'ecstasy', is associated with significant cognitive impairments, particularly in laboratory and field tests of memory for previously encoded material. Less is known about the effects of a history of MDMA use on aspects of everyday cognitive